Monitoring immunotherapy outcomes with circulating tumor DNA

Immunotherapy. 2018 Sep;10(12):1023-1025. doi: 10.2217/imt-2018-0084.
No abstract available

Keywords: cell-free DNA; circulating tumor DNA; ctDNA; immune checkpoint inhibitor; immunotherapy; lung cancer.

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use*
  • B7-H1 Antigen / immunology
  • Biomarkers, Pharmacological / analysis*
  • Carcinoma, Non-Small-Cell Lung / immunology
  • Carcinoma, Non-Small-Cell Lung / therapy*
  • Circulating Tumor DNA / analysis*
  • Humans
  • Immunotherapy / methods*
  • Lung Neoplasms / immunology
  • Lung Neoplasms / therapy*
  • Monitoring, Immunologic
  • Patient Selection
  • Prognosis
  • Programmed Cell Death 1 Receptor / immunology

Substances

  • Antibodies, Monoclonal
  • B7-H1 Antigen
  • Biomarkers, Pharmacological
  • Circulating Tumor DNA
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor